Lasa Supergenerics reported a significant loss before tax of **₹34.61 Cr** for the year ended March 31, 2026, a substantial increase from ₹19.38 Cr loss last year.

The results are heavily impacted by operational disruptions.

Auditors issued a qualified opinion due to the unassessed financial impact of a major fire at its factory in May 2025, including a provisional **₹7 Cr** impairment on tangible assets, and unassessed impairment on **₹16.67 Cr** intangible assets.

The affected assets were uninsured, and the actual losses are still unquantified.

The company also faces contested GST demands of **₹38.11 Cr** without provision.

These results reflect a weak financial momentum, with significant unquantified risks and ongoing operational challenges.